Pine Pharmaceuticals is recalling 136 units of Brilliant Blue G for Intraocular Injection (0.25 mg/mL) after discovering a labeling mix-up. The medication vials were labeled with an inaccurate auxiliary label that lists active and inactive ingredients meant for an entirely different product. This recall affects products sold exclusively in New York that were distributed in 0.5mL vials.
The presence of an incorrect ingredient label could lead to medical errors if healthcare providers rely on the inaccurate information during patient care. While the medication inside the vial is correct, the auxiliary label describes the wrong chemical components, potentially leading to confusion regarding the drug's composition.
Product return and pharmacist consultation
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.